Edition:
United Kingdom

Zai Lab Ltd (ZLAB.OQ)

ZLAB.OQ on NASDAQ Stock Exchange Global Market

18.35USD
7:00pm BST
Change (% chg)

$-0.09 (-0.49%)
Prev Close
$18.44
Open
$18.58
Day's High
$18.85
Day's Low
$18.25
Volume
10,588
Avg. Vol
20,840
52-wk High
$35.60
52-wk Low
$17.98

Latest Key Developments (Source: Significant Developments)

Five Prime Therapeutics And Zai Lab Announce Exclusive License Agreement
Tuesday, 19 Dec 2017 

Dec 19 (Reuters) - Five Prime Therapeutics Inc ::FIVE PRIME THERAPEUTICS AND ZAI LAB ANNOUNCE EXCLUSIVE LICENSE AGREEMENT FOR FPA144 ANTI-FGFR2B ANTIBODY IN GREATER CHINA AND GLOBAL STRATEGIC DEVELOPMENT COLLABORATION.FIVE PRIME THERAPEUTICS - GRANTED ZAI LAB AN EXCLUSIVE LICENSE TO DEVELOP AND COMMERCIALIZE FPA144 IN GREATER CHINA TERRITORY​.FIVE PRIME THERAPEUTICS INC - ‍ZAI LAB WILL BE RESPONSIBLE FOR CONDUCTING PHASE 3 FIGHT TRIAL IN GREATER CHINA​.  Full Article

BRIEF-Entasis Therapeutics And Zai Lab Announce Exclusive License Agreement In Asia-Pacific And Global Strategic Development Collaboration For ETX2514

* ENTASIS THERAPEUTICS AND ZAI LAB ANNOUNCE EXCLUSIVE LICENSE AGREEMENT IN ASIA-PACIFIC AND GLOBAL STRATEGIC DEVELOPMENT COLLABORATION FOR ETX2514

No consensus analysis data available.